申请人:Shionogi & Co., Ltd.
公开号:EP2952503A1
公开(公告)日:2015-12-09
The present invention provides a novel compound having an antiviral activity, in particular, an HIV replication inhibiting activity, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein ring A is substituted or unsubstituted carbocycle or substituted or unsubstituted heterocycle; R1 is substituted or unsubstituted alkyl etc.; R2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R3 is substituted or unsubstituted carbocyclyl or substituted or unsubstituted heterocyclyl; R4 is a hydrogen atom etc.; R6 is substituted or unsubstituted alkyl etc.
本发明提供了一种具有抗病毒活性,特别是抑制艾滋病毒复制活性的新型化合物,以及一种药物组合物,特别是一种抗艾滋病毒制剂。
其中环 A 是取代或未取代的碳环或取代或未取代的杂环;R1 是取代或未取代的烷基等;R2 是取代或未取代的烷氧基等;n 是 1 或 2;R3 是取代或未取代的碳环或取代或未取代的杂环;R4 是氢原子等;R6 是取代或未取代的烷基等。